Replimune Group (REPL) Enterprise Value

Price: $7.45
Market Cap: $573.76M
Avg Volume: 749.55K
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 1.265
52W Range: $4.92-17
Website: Replimune Group
Enterprise Value Summary (Quarterly)

According to Replimune Group's latest quarterly financial reports:

  • The enterprise value (EV) is 869.01M, which includes the market capitalization, debt, and subtracts cash and cash equivalents. EV provides a more comprehensive measure of a company's total value.
  • The market capitalization is 514.59M, which is calculated by multiplying the current share price by the total number of outstanding shares.
  • The stock price is $12.11, with 83.50M shares outstanding.
  • The company has 172.25M in cash and cash equivalents and 30.08M in total debt.

Enterprise Value (EV) Formula:

EV = Market Cap + Total Debt - Cash and Cash Equivalents

Enterprise value is often used instead of market cap because it provides a more accurate valuation of a company by including debt and subtracting cash, giving a fuller picture of the company's total value.

Enterprise Value

$869.01M

Market Cap

$1.01B

Total Debt

$30.08M

Cash and Equivalents

$172.25M

Historical Enterprise Value
$2.00B$2.00B$1.50B$1.50B$1.00B$1.00B$500.00M$500.00M$0.00$0.00Enterprise Value20182018201920192020202020212021202220222023202320242024
Replimune Group Historical Enterprise Values

The table below shows various enterprise value metrics for each quarter, with the latest data available for 2024-12-31.

Date Enterprise Value EV Change (%) Stock Price Number of Shares Market Cap Cash & Equivalents Total Debt
December 31, 2024 $869.01M 5.49% $12.11 83.50M $1.01B $172.25M $30.08M
September 30, 2024 $823.76M 44.05% $10.96 78.57M $861.13M $113.49M $76.12M
June 30, 2024 $571.87M 20.10% $9.36 69.19M $647.58M $151.66M $75.95M
March 31, 2024 $476.15M -11.82% $7.73 61.42M $474.74M $74.46M $75.87M
December 31, 2023 $539.96M -51.96% $8.43 66.65M $561.82M $97.67M $75.81M
September 30, 2023 $1.12B -24.84% $17.11 66.58M $1.14B $76.00M $60.74M
June 30, 2023 $1.50B 63.42% $23.22 66.37M $1.54B $106.48M $60.84M
March 31, 2023 $915.07M -35.89% $17.66 56.68M $1.00B $146.59M $60.76M
December 31, 2022 $1.43B 60.56% $27.2 57.86M $1.57B $206.67M $60.40M
September 30, 2022 $889.04M 2.44% $17.27 54.77M $945.88M $88.93M $32.09M
June 30, 2022 $867.84M 18.77% $17.48 54.21M $947.62M $112.25M $32.47M
March 31, 2022 $730.70M -44.59% $16.98 47.34M $803.81M $105.95M $32.84M
December 31, 2021 $1.32B -6.91% $27.1 52.32M $1.42B $132.28M $33.10M
September 30, 2021 $1.42B -22.80% $29.64 52.08M $1.54B $159.97M $32.91M
June 30, 2021 $1.83B 44.32% $38.42 51.91M $1.99B $192.53M $33.13M
March 31, 2021 $1.27B -20.18% $30.51 46.57M $1.42B $182.52M $33.28M
December 31, 2020 $1.59B 57.22% $38.15 49.38M $1.88B $324.48M $33.42M
September 30, 2020 $1.01B 9.07% $23.02 44.02M $1.01B $43.33M $43.23M
June 30, 2020 $928.93M 151.53% $24.85 39.86M $990.58M $104.80M $43.15M
March 31, 2020 $369.31M -22.99% $9.97 38.82M $387.03M $59.50M $41.79M
December 31, 2019 $479.54M 17.98% $14.35 34.88M $500.50M $63.00M $42.05M
September 30, 2019 $406.47M 0.21% $13.9 31.68M $440.29M $53.30M $19.48M
June 30, 2019 $405.63M -13.51% $14 31.66M $443.26M $38.36M $730.00K
March 31, 2019 $468.98M 56.49% $15.5 31.49M $488.13M $25.70M $6.56M
December 31, 2018 $299.69M -16.60% $10 31.58M $315.77M $21.05M $4.97M
September 30, 2018 $359.34M -20.96% $15.57 24.57M $382.62M $23.28M $-
June 30, 2018 $454.60M 684.76% $15.16 30.84M $467.51M $12.91M $-
March 31, 2018 $57.93M -79.80% $15.16 4.98M $75.51M $17.58M $-
December 31, 2017 $286.84M -12.02% $15.16 21.51M $326.04M $39.20M $-
September 30, 2017 $326.04M -5.94% $15.16 21.51M $326.04M $- $-
June 30, 2017 $346.64M 532.58% $15.16 21.51M $326.04M $-20.59M $-
March 31, 2017 $54.80M - $15.16 4.97M $75.39M $20.59M $-

Related Metrics

Explore detailed financial metrics and analysis for REPL.